The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
01/24/2009
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Description of Modification
Page 5 of the Application Instructions & General Information document - Under the section "B. Step 2 - Application Submission," a block containing the following erroneous information was removed: “All applications must be submitted electronically through the CDMRP eReceipt system by 11:59 p.m. Eastern time on the deadline identified in the specific Program Announcement/Funding Opportunity. Material submitted after the application submission deadline, unless specifically requested by the Government, will not be forwarded for processing. Failure to meet this deadline shall result in application rejection.”
Document Type:
Modification to Previous
Grants Notice
Funding Opportunity Number:
W81XWH-09-PCRP-IDA
Opportunity Category:
Discretionary
Posted Date:
Jan 24, 2009
Creation Date:
May 05, 2009
Original Closing Date for Applications:
Jun 10, 2009
Current Closing Date for Applications:
Jun 10, 2009
Archive Date:
Jul 10, 2009
Funding Instrument Type:
Cooperative Agreement
Grant
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
40
Estimated Total Program Funding:
$28,800,000
Award Ceiling:
Award Floor:
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
The PCRP Idea Development Award mechanism was introduced in FY97. Since then, 4,957 applications have been received and 881 have been recommended for funding. The Idea Development Award supports innovative approaches to prostate cancer research that make an important contribution to prevention, detection, diagnosis, and/or treatment. The PCRP seeks applications from all areas of basic, preclinical, behavioral, and epidemiological research, that are responsive to one or more of the FY09 PCRP focus areas. NEW FOR FY09: PIs wishing to apply for funding for population-based studies should consider submitting an application for the Population-Based Idea Development Award. NOTE: Clinical trials are not allowed under this mechanism. Refer to the Application Instructions and General Information, Appendix 6, for helpful information about distinguishing clinical trials and clinical research. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate how the project addresses the following important aspects of the Idea Development Award:1. Innovation: Innovative research may represent a new paradigm, challenge existing paradigms, or look at existing problems from new perspectives. This may include high-risk approaches to prostate cancer research provided that there is potential for significant impact. Research that is an incremental advance upon published data is not considered innovative and will not be considered for funding under this award mechanism.2. Impact: Research that has high impact will, if successful, significantly advance current methods and concepts for the prevention, detection, diagnosis, or treatment of prostate cancer in humans.3. Responsiveness to focus areas: The relevance of the research problem to one or more of the focus areas.4. Preliminary Data: Submission of preliminary data relevant to prostate cancer and the proposed project is encouraged but not required. Any preliminary data provided should be from the laboratory of the PI or member(s) of the collaborating team. Although groundbreaking research often involves a degree of risk due to unforeseen difficulties or results, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature. See the Program Announcement for the full Funding Opportunity Description.
Link to Full Announcement
If you have difficulty accessing the full announcement
electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org
CDMRP Helpdesk
Synopsis Modification History
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.
